Cape Investment Advisory, Inc. Ligand Pharmaceuticals Inc Put Options Transaction History
Cape Investment Advisory, Inc.
- $256 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
273Shares Held
18.7MCall Options Held
19.6KPut Options Held
4.7K-
Black Rock Inc. New York, NY2.87MShares$305 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$219 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$109 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$96.4 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$79.2 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.8B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...